In recent studies, miR-489-3p was shown to interact with the PI3K/AKT/mTOR signaling in various cancers, such as glioma, breast cancer, and melanoma (Chen et al., 2016, 2017; Li et al., 2017). This evidence concerns the gene AKT1 and central nervous system cancer.